M120 Risk Score Improves Identification of Children at High Risk of Developing Clinical Type 1 Diabetes and Reports Short-term Response to Preventive Immunotherapy

What is it about?

This manuscript describes a simpler way to find children who are at risk of developing type 1 diabetes and of measuring their response to new treatment called immunotherapy. The new test, called M120, involves collection of a blood sample 120 minutes after drinking a sugary drink.

Featured Image